Siam Capital
Siam Capital is a venture capital firm based in New York, founded in 2021. The firm is dedicated to investing in companies at the intersection of sustainability, consumer needs, and technology. Its focus is on identifying and supporting innovative ventures that aim to improve both people's lives and the health of the planet. By targeting sectors that promote sustainable practices and technological advancements, Siam Capital seeks to facilitate positive change and drive progress in the marketplace.
Past deals in Infants
Helaina
Series B in 2024
Helaina is a biotechnology company dedicated to producing milk-equivalent baby formula designed as a breast milk alternative. By utilizing fermentation technology, Helaina creates bioactive proteins that replicate the functional proteins found in human breast milk, thereby offering a new category of functional food products. These products not only provide essential nutrients but also deliver immune benefits, positioning Helaina as a pioneer in the infant nutrition sector. The company's innovative approach aims to provide infants with nutritional options that closely resemble the composition and benefits of breast milk, addressing the needs of families seeking alternatives.
Evereden
Series C in 2021
Evereden is a skincare brand focused on promoting skin health for the entire family, specializing in baby-safe and anti-allergic cosmetics. The company offers a range of self-care products crafted from high-quality natural ingredients, including cold-processed organic sunflower seed oil, avocado oil, and grapeseed oil. Its product lineup features creams, healing balms, firming lotions, and belly masks, designed to meet the needs of both parents and their infants. Evereden aims to provide safe and nourishing skincare solutions that prioritize the well-being of families.
Helaina
Series A in 2021
Helaina is a biotechnology company dedicated to producing milk-equivalent baby formula designed as a breast milk alternative. By utilizing fermentation technology, Helaina creates bioactive proteins that replicate the functional proteins found in human breast milk, thereby offering a new category of functional food products. These products not only provide essential nutrients but also deliver immune benefits, positioning Helaina as a pioneer in the infant nutrition sector. The company's innovative approach aims to provide infants with nutritional options that closely resemble the composition and benefits of breast milk, addressing the needs of families seeking alternatives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.